Skip to main content

Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study.

Agarwal SK, Avery CL, Ballantyne CM, Catellier D, Nambi V, Saunders J, Sharrett AR, Coresh J, Heiss G, Hoogeveen RC

Publication: Clin Chem (2011) • Vol 57 • Page 891-7PMID: 21519038View on PubMed

Purpose

The purpose of this paper was to determine the combined effects of intraindividual variability, repeated sampling, and frozen storage on plasma cardiac troponin T (cTnT) levels.

Conclusion

The coefficient of variance (CV) due to a combination of intraindividual variability and frozen storage for 4-8 weeks was less than that from specimen handling, but specimens obtained (and stored) 8 years apart had a much higher CV. cTnT levels declined on average by 0.36 ng/L during the first year of storage.

Studies (1)

Purpose

The purpose of this study was to determine the effects of intraindividual variability, repeated sampling, and frozen storage on plasma cTnT levels. Plasma was stored at -70 degrees C and shipped at weekly intervals, under unspecified conditions, to a central lab where it was stored at -70 degrees C for up to 8 years. In some cases multiple specimens were collected from a single venipuncture and handled individually, but in other cases the plasma was aliquoted at first analysis and then stored for less than 2 days prior to repeat analysis. Specimens from the same individual were acquired 4-8 weeks and 8 years after the initial specimen.

Summary of Findings

Specimens taken from the same individual 4-8 weeks apart had a CV of 16.6%, but replicate specimens from the same venipuncture that were mailed and processed separately had a CV of 18.3%. In contrast, the intraindividual variability between specimens obtained (and stored) 8 years apart was 48.4%, and only a weak correlation of values was observed (r=0.36). In specimens collected and stored for 36 months, cTnT levels declined by an average of 0.36 ng/L during the first year. cTnT levels were approximately 3-fold higher in individuals with heart failure than those without. Repeated assaying of the same specimen 2 days later gave a CV of 2.1% in individuals with heart failure and 11.2% in those without.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Cardiovascular Disease
    Not specified
  • Platforms

    ProteinClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Heart failure
    No heart failure
    Biospecimen AcquisitionTime of biospecimen collection
    4-8 weeks later
    8 years later
    Day 0
    StorageStorage duration
    0 days
    0-3 years
    2 days
    4-8 weeks
    8 years